Found: 5
Select item for more details and to access through your institution.
Cre‐loxP mediated control of PrP to study transmissible spongiform encephalopathy diseases.
- Published in:
- Genesis: The Journal of Genetics & Development, 2004, v. 40, n. 1, p. 1, doi. 10.1002/gene.20046
- By:
- Publication type:
- Article
Dramatic Reduction of PrP<sup>C</sup> Level and Glycosylation in Peripheral Nerves following PrP Knock-Out from Schwann Cells Does Not Prevent Transmissible Spongiform Encephalopathy Neuroinvasion.
- Published in:
- Journal of Neuroscience, 2009, v. 29, n. 49, p. 15445, doi. 10.1523/JNEUROSCI.4195-09.2009
- By:
- Publication type:
- Article
A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy.
- Published in:
- EMBO Journal, 1999, v. 18, n. 23, p. 6855, doi. 10.1093/emboj/18.23.6855
- By:
- Publication type:
- Article
Host PrP Glycosylation: A Major Factor Determining the Outcome of Prion Infection.
- Published in:
- PLoS Biology, 2008, v. 6, n. 4, p. e100, doi. 10.1371/journal.pbio.0060100
- By:
- Publication type:
- Article
NCL-CB11, a new monoclonal antibody recognizing the internal domain of the c- erbB-2 oncogene protein effective for use on formalin-fixed, paraffin-embedded tissue.
- Published in:
- Journal of Pathology, 1990, v. 161, n. 1, p. 15, doi. 10.1002/path.1711610105
- By:
- Publication type:
- Article